Fachbeirat_header.jpg

Scientific Advisory Board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent advisory boards. The board members, experts from leading international research institutions and universities, are selected by the president of the Max Planck Society on the basis of suggestions from the institutes. They are elected to the board for a maximum term of six years.

Our institute's Scientific Advisory Board is currently composed of 25 members:

  • Prof. Dr. Julie Ahringer,
    Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
  • Prof. Dr. Peer Bork,
    Structural and Computational Biology, EMBL Heidelberg, Germany
  • Prof. Dr. Cynthia J. Burrows,
    Department of Chemistry, The University of Utah, USA
  • Prof. Dr. David W. Chandler,
    Sandia National Laboratories, California, USA
  • Prof. Dr. Thomas W. Ebbesen,
    ISIS, Laboratoire des Nanostructures, Strasbourg Cedex, France
  • Prof. Dr. Witold Filipowicz,
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
  • Prof. Dr. Lucio Frydman,
    Department of Chemical and Biological Physics, Weizman Institute of Science, Rehovot, Israel
  • Prof. Dr. Astrid Gräslund,
    Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
  • Prof. Dr. Angela Gronenborn,
    Department of Structural Biology, University of Pittsburgh, Pittsburgh, USA
  • Prof. Dr. Rebecca W. Heald,
    Department of Molecular & Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Johan Hofkens,
    Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
  • Prof. Dr. Laurinda Jaffe,
    School of Medicine, University of Connecticut, Farmington, USA
  • Prof. Dr. Ute Kaiser,
    Electron Microscopy Group of Materials Science, Universität Ulm, Ulm, Germany
  • Prof. Dr. Kinneret Keren,
    Physics Department, Technion – Israel Institute of Technology, Haifa, Israel
  • Prof. Dr. Iain Mattaj (Vorsitzender des Fachbeirats),
    Fondazione Human Technopole, Milano, Italy
  • Prof. Dr. Ann McDermott,
    Department of Chemistry, Columbia University, New York, USA
  • Prof. Dr. Jane Mellor,
    Department of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Daniel M. Neumark,
    College of Chemistry, University of California, Berkeley, USA
  • Prof. Dr. Anna Marie Pyle,
    Biological & Biomedical Sciences, Yale University, New Haven, USA
  • Prof. Dr. José Rizo-Rey,
    Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, USA
  • Prof. Dr. Randy Schekman,
    Department of Molecular and Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Thomas U. Schwartz,
    Department of Biology, Massachussetts Institute of Technology, Cambridge, USA
  • Prof. Dr. Jeremy C. Smith,
    Oak Ridge National Laboratory, Oak Ridge, USA
  • Prof. Dr. Peter Tieleman,
    Biocomputing, University of Calgary, Calgary, Canada
  • Prof. Dr. Joachim Wittbrodt,
    Centre for Organismal Studies, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany

 

Go to Editor View